Core Laboratories Inc. (CLB) stock
Close on Nov 11, 2026Market cap $414.24MP/E 26.6Yield 0.44%
Core Laboratories Inc. saw revenue fall 0.1% to $516.74M over the twelve months to Sep 30, 2026. Operating income fell 29.0% to $38.94M, moving the operating margin from 10.6% to 7.5%. Free cash flow was $10.36M, down 72.9% from a year earlier. At the latest close the market valued the company at $414.24M, 26.6 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $414.24M
- P/E ratio
- 26.6
- Price to sales
- 0.80
- Price to book
- 1.49
- Dividend yield
- 0.44%
- Free cash flow yield
- 2.50%
Fundamentals
- Revenue
- $516.74M
- Net income
- $15.56M
- EPS, diluted
- $0.34
- Free cash flow
- $10.36M
- Book value per share
- $5.95
- Diluted shares
- 47M
Trading
- Next earnings
- Feb 3, 2027 (estimated, after the close)
- Previous close
- $8.95
- Open
- $9.09
- Day's range
- $8.98 – $9.24
- Volume
- 446,299
- Average volume (20 days)
- 679,680
- Index membership
- S&P SmallCap 600 (since May 2023), Russell 2000 (since Jun 2023), Russell 3000 (since Aug 2023)
- Beta (5 years)
- 1.14
- 52-week range
- $8.61 – $20.36
- RSI (14 days)
- 36.1
- Volatility (1 year)
- 46.7%
- Relative volume
- 0.69×
- WACC
- 9.7%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CLB | S&P 500 | Difference | CLB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.4% | -2.4% | −8.0 pts | ||
| 3 months | -27.3% | -1.2% | −26.1 pts | ||
| Year to date | -43.5% | +12.3% | −55.8 pts | ||
| 1 year | -43.9% | +12.4% | −56.3 pts | ||
| 3 years | -53.0% | +78.8% | −131.8 pts | -22.2% | +21.4% |
| 5 years | -65.5% | +75.2% | −140.7 pts | -19.2% | +11.9% |
| 10 years | -90.4% | +311.1% | −401.5 pts | -20.9% | +15.2% |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Core Laboratories filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About Core Laboratories
Oil & Gas Field Services, NEC
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry. The company operates through two segments: Reservoir Description and Production Enhancement. Its Reservoir Description segment characterizes petroleum reservoir rock and fluid samples to help clients evaluate reservoir performance and increase recovery, while also supporting energy transition projects such as carbon capture and geothermal initiatives. The Production Enhancement segment offers perforating products, diagnostic services, and well completion solutions to optimize well stimulation and field development. The company serves major, national, and independent oil companies, as well as universities and research facilities.
Company profile, executives and historyCore Laboratories stock: common questions
What is Core Laboratories's stock price?
CLB closed at $9.04 on Nov 11, 2026, up 1.01% on the day. Over the past 52 weeks it traded between $8.61 and $20.36.
What is Core Laboratories's market cap?
Core Laboratories was worth $414.24M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CLB's P/E ratio?
CLB trades at 26.6 times earnings, based on diluted earnings per share of $0.34 over the twelve months to Sep 30, 2026.
How much revenue does Core Laboratories make?
Core Laboratories reported revenue of $516.74M for the twelve months to Sep 30, 2026, down 0.1% from a year earlier.
Does Core Laboratories pay a dividend?
Yes. Core Laboratories paid $0.04 per share over the last twelve months, a yield of 0.44% at the latest price.
When does Core Laboratories report earnings next?
Core Laboratories is expected to report Q4 FY2026 results on Feb 3, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has CLB stock performed over the past year?
Including dividends, CLB returned -43.9% over the past year, against +12.4% for the S&P 500.
How many CLB shares are sold short?
5M shares were sold short at the latest FINRA report, 10.97% of the float, or 6.8 days of average trading volume.
Who are Core Laboratories's competitors?
Companies most similar to Core Laboratories by business, industry and size include NINE, XPRO, KLXE, NESR, RNGR.
See a number that looks wrong?